1. Selective estrogen receptor modulators in chronic renal failure
José R. Weisinger, Ita Pfeferman Heilberg, Eddy Hernández, Raul Carlini, Ezequiel Bellorin-Font 
Kidney International 
Volume 63, Pages S62-S65 (June 2003)
DOI: /j s85.15.x
Copyright © 2003 International Society of Nephrology Terms and Conditions

2. Figure 1
Changes in lumbar spine BMD (g/cm2) in postmenopausal hemodialyzed women given raloxifene 60mg/day or placebo for one year. Open bars represent values at baseline and the closed bars after one year of treatment. *P < 0.01.
Kidney International  , S62-S65DOI: ( /j s85.15.x)
Copyright © 2003 International Society of Nephrology Terms and Conditions

3. Figure 2
Changes in lumbar spine BMD (g/cm2), Z-, and T-scores according to the estrogen receptor polymorphism (for homozygous PP or XX (A) and heterozygous PpXx women (B). Open bars represent values at baseline and the closed bars after one year of treatment. *P < 0.05.
Kidney International  , S62-S65DOI: ( /j s85.15.x)
Copyright © 2003 International Society of Nephrology Terms and Conditions